|
|
|
ACETYLCHOLINE SIGNALING PATHWAY (PW:0000841)
Description
Acetylcholine (ACh) is a major neurotransmitter and neuromodulator that plays important roles in the central and peripheral nervous systems, the autonomic nervous system (ANS), and also in non-neuronal cells. In cholinergic neurons acetylcholine is synthetized from acetyl-CoA and choline by the choline O-acetyltransferase Chat. The glucose-derived pyruvate metabolism is the primary source of acetyl-CoA in the brain. Once synthesized, ACh is loaded into synaptic vesicles by the vesicular ACh transporter Slc18a3, known as VACht. Upon release, ACh activates two types of receptors: the ionotropic nicotinic (nAChRs) [ click, to access the page] and the metabotropic muscarinic (mAChRs) [ click to access the page] receptors. The signal is rapidly terminated by the hydrolysis of ACh carried out by the acetylcholine esterase Ache; the resulting choline is up-taken by the high affinity transporter Slc5a7, known as Cht1. Ache is very fast acting enzyme and Ach clearance occurs in less than a millisecond. The ionotropic nicotinic receptors are part of the Cys-loop ligand-gated ion channel superfamily that form homo- and heteropentamers. The mAChRs are G-protein coupled receptors (GPCRs) that are subdivided into two families, depending on the type of G protein to which they couple. The two receptor types derive their names because in addition to the endogenous ACh ligand they can be activated by nicotine, an alkaloid found in tobacco and other plants and by muscarine, a natural product of certain mushrooms. In the autonomic nervous system (ANS), the part of the peripheral nervous system whose sympathetic and parasympathetic branches mediate the various responses that generally are below conscious control, referred to as visceral, ACh plays a central role. Ach is released from both the sympathetic and parasympathetic preganglions and from the parasympathetic postganglions. The ACh receptors of both sympathetic and parasympathetic postganglions are the nicotinic receptors while the muscarinic receptors are on the cell membrane of effector tissues. Most sympathetic postganglions release the norepinephrine neurotransmitter that activate adrenergic receptors on terminal effectors (not shown). Sympathetic preganglions also synapse directly on the adrenal medulla, the part of the adrenal gland whose cells are derived from the embryonic neural crest and is actually considered a ganglion of the sympathetic nervous system. However, unlike the regular sympathetic postganglions, the adrenal medulla releases hormones into the blood, rather than neurotransmitter in response to Ach. ~20% of its output is norepinephrine, the rest is epinephrine; the adrenal medulla has the methyltransferase that methylates norepinephrine to produce epinephrine. The two molecules, referred to as catecholamines, are agonists for the adrenergic receptors (not shown). The two divisions of the autonomic nervous system elicit different and opposite functions that are complementary rather than antagonistic. The sympathetic nervous system accounts for the 'fight or flight' response while the parasympathetic accounts for the 'rest and digest' - together, promoting the system's homeostasis. The diagram is intended to provide an overall picture of acetylcholine function and as such does not portray the details of those autonomic responses beyond the function of ACh. In the somatic peripheral nervous system, Ach mediates muscle contraction in the skeletal muscle fiber via activation of nicotinic receptors. In the central nervous system Ach signaling via both receptor types plays important roles in hippocampal plasticity and is also involved in cognition, learning and emotion. Ach signaling is also important in development, the regulation of immune responses and in non-neuronal cells. Opening of nAChRs leads to membrane depolarization to generate firing and modulate excitability of the postsynaptic neuron while the presynaptic receptors are involved in the modulation of neurotransmitter release. The mAChRs are expressed both pre and post-synaptically. The presynaptic receptors act as inhibitory auto-receptors to control Ach release; the postsynaptic receptors exert both inhibitory and excitatory roles via activation of particular G proteins. The deregulation of acetylcholine signaling system has been associated with a range of conditions, including neurodegenerative, depression and schizophrenia and muscular disorders. Exposure to organophosphates, compounds found in pesticides and insecticides, inhibit Ache leading to uncensored activation of both nAChRs and mAChRs. In addition to addiction, nicotine in high amounts can exert harmful toxic effects. ...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
|
|
| G
|
Ache
|
acetylcholinesterase
|
|
ISO
|
|
RGD |
PMID:17786266 |
RGD:8549506 |
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Chat
|
choline O-acetyltransferase
|
|
ISO
|
|
RGD |
PMID:23677775 |
RGD:8549504 |
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
|
|
| G
|
Grk2
|
G protein-coupled receptor kinase 2
|
|
ISO
|
|
RGD |
PMID:23759942 |
RGD:8549590 |
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:211,009,978...211,031,015
|
|
| G
|
Grk5
|
G protein-coupled receptor kinase 5
|
|
ISO
|
|
RGD |
PMID:19478075 |
RGD:8549592 |
NCBI chr 1:270,014,314...270,208,294
Ensembl chr 1:270,014,282...270,204,928
|
|
| G
|
Rgs2
|
regulator of G-protein signaling 2
|
|
ISO
|
|
RGD |
PMID:22685433 |
RGD:8549594 |
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697
|
|
| G
|
Rgs4
|
regulator of G-protein signaling 4
|
|
ISO
|
|
RGD |
PMID:22685433 |
RGD:8549594 |
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884
|
|
| G
|
Rgs6
|
regulator of G-protein signaling 6
|
|
ISO
|
|
RGD |
PMID:22685433 |
RGD:8549594 |
NCBI chr 6:107,875,883...108,527,472
Ensembl chr 6:107,876,039...108,555,840
|
|
| G
|
Slc18a3
|
solute carrier family 18 member A3
|
|
ISO
|
|
RGD |
PMID:23677775 |
RGD:8549504 |
NCBI chr16:7,719,953...7,722,814
|
|
| G
|
Slc5a7
|
solute carrier family 5 member 7
|
|
ISO
|
|
RGD |
PMID:23677775 |
RGD:8549504 |
NCBI chr 9:7,922,693...7,953,509
Ensembl chr 9:7,922,697...7,953,509
|
|
|
|
| G
|
Chrm2
|
cholinergic receptor, muscarinic 2
|
|
ISO
|
|
RGD |
PMID:23841840 |
RGD:8549585 |
NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464
|
|
| G
|
Chrm4
|
cholinergic receptor, muscarinic 4
|
|
ISO
|
|
RGD |
PMID:23841840 |
RGD:8549585 |
NCBI chr 3:98,349,080...98,356,821
Ensembl chr 3:98,348,650...98,358,771
|
|
| G
|
Gnai1
|
G protein subunit alpha i1
|
|
ISO
|
|
RGD |
PMID:23759942 |
RGD:8549590 |
NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198
|
|
| G
|
Gnai2
|
G protein subunit alpha i2
|
|
ISO
|
|
RGD |
PMID:23759942 |
RGD:8549590 |
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
|
|
|
|
| G
|
Chrm1
|
cholinergic receptor, muscarinic 1
|
|
ISO
|
|
RGD |
PMID:23841840 |
RGD:8549585 |
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602
|
|
| G
|
Chrm3
|
cholinergic receptor, muscarinic 3
|
|
ISO
|
|
RGD |
PMID:23841840 |
RGD:8549585 |
NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304
|
|
| G
|
Chrm5
|
cholinergic receptor, muscarinic 5
|
|
ISO
|
|
RGD |
PMID:23841840 |
RGD:8549585 |
NCBI chr 3:119,739,229...119,791,630
Ensembl chr 3:119,735,975...119,792,166
|
|
| G
|
Gna11
|
G protein subunit alpha 11
|
|
ISO
|
|
RGD |
PMID:23759942 |
RGD:8549590 |
NCBI chr 7:8,814,285...8,828,628
Ensembl chr 7:8,814,327...8,830,558
|
|
| G
|
Gna14
|
G protein subunit alpha 14
|
|
ISO
|
|
RGD |
PMID:23759942 |
RGD:8549590 |
NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210
|
|
| G
|
Gnaq
|
G protein subunit alpha q
|
|
ISO
|
|
RGD |
PMID:23759942 |
RGD:8549590 |
NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
|
ISO
|
|
RGD |
PMID:17786266 |
RGD:8549506 |
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Agrn
|
agrin
|
|
ISO
|
|
RGD |
PMID:23032192 |
RGD:8549508 |
NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539
|
|
| G
|
Chat
|
choline O-acetyltransferase
|
|
ISO
|
|
RGD |
PMID:23677775 |
RGD:8549504 |
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
|
|
| G
|
Chrna1
|
cholinergic receptor nicotinic alpha 1 subunit
|
|
ISO
|
|
RGD |
PMID:23032192 PMID:19126755 |
RGD:8549508, RGD:8549510 |
NCBI chr 3:78,862,286...78,877,353
Ensembl chr 3:78,862,286...78,877,353
|
|
| G
|
Chrna10
|
cholinergic receptor nicotinic alpha 10 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr 1:165,898,932...165,905,348
Ensembl chr 1:165,899,261...165,903,458
|
|
| G
|
Chrna2
|
cholinergic receptor nicotinic alpha 2 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144
|
|
| G
|
Chrna3
|
cholinergic receptor nicotinic alpha 3 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrna5
|
cholinergic receptor nicotinic alpha 5 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:64,265,879...64,294,233
|
|
| G
|
Chrna6
|
cholinergic receptor nicotinic alpha 6 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr16:71,400,615...71,407,315
Ensembl chr16:71,400,615...71,407,315
|
|
| G
|
Chrna7
|
cholinergic receptor nicotinic alpha 7 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858
|
|
| G
|
Chrna9
|
cholinergic receptor nicotinic alpha 9 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr14:42,588,948...42,595,669
Ensembl chr14:42,588,948...42,595,669
|
|
| G
|
Chrnb1
|
cholinergic receptor nicotinic beta 1 subunit
|
|
ISO
|
|
RGD |
PMID:23032192 PMID:19126755 |
RGD:8549508, RGD:8549510 |
NCBI chr10:54,999,943...55,015,137
Ensembl chr10:55,002,788...55,015,107
|
|
| G
|
Chrnb2
|
cholinergic receptor nicotinic beta 2 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
|
|
| G
|
Chrnb3
|
cholinergic receptor nicotinic beta 3 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr16:71,411,847...71,454,225
Ensembl chr16:71,417,039...71,454,225
|
|
| G
|
Chrnb4
|
cholinergic receptor nicotinic beta 4 subunit
|
|
ISO
|
|
RGD |
PMID:19126755 |
RGD:8549510 |
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
|
|
| G
|
Chrnd
|
cholinergic receptor nicotinic delta subunit
|
|
ISO
|
|
RGD |
PMID:23032192 PMID:19126755 |
RGD:8549508, RGD:8549510 |
NCBI chr 9:95,310,316...95,318,734
Ensembl chr 9:95,310,298...95,318,745
|
|
| G
|
Chrne
|
cholinergic receptor nicotinic epsilon subunit
|
|
ISO
|
|
RGD |
PMID:23032192 PMID:19126755 |
RGD:8549508, RGD:8549510 |
NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154
|
|
| G
|
Chrng
|
cholinergic receptor nicotinic gamma subunit
|
|
ISO
|
|
RGD |
PMID:23032192 PMID:19126755 |
RGD:8549508, RGD:8549510 |
NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:95,325,984...95,332,092
|
|
| G
|
Dok7
|
docking protein 7
|
|
ISO
|
|
RGD |
PMID:23032192 |
RGD:8549508 |
NCBI chr14:79,890,051...79,924,081
Ensembl chr14:79,891,367...79,932,252
|
|
| G
|
Lrp4
|
LDL receptor related protein 4
|
|
ISO
|
|
RGD |
PMID:23032192 |
RGD:8549508 |
NCBI chr 3:97,885,373...97,939,366
Ensembl chr 3:97,885,400...97,939,370
|
|
| G
|
Musk
|
muscle associated receptor tyrosine kinase
|
|
ISO
|
|
RGD |
PMID:23032192 |
RGD:8549508 |
NCBI chr 5:77,853,560...77,967,653
Ensembl chr 5:77,853,736...77,964,338
|
|
| G
|
Rapsn
|
receptor-associated protein of the synapse
|
|
ISO
|
|
RGD |
PMID:23032192 |
RGD:8549508 |
NCBI chr 3:97,470,891...97,480,196
Ensembl chr 3:97,470,881...97,480,196
|
|
| G
|
Slc18a3
|
solute carrier family 18 member A3
|
|
ISO
|
|
RGD |
PMID:23677775 |
RGD:8549504 |
NCBI chr16:7,719,953...7,722,814
|
|
| G
|
Slc5a7
|
solute carrier family 5 member 7
|
|
ISO
|
|
RGD |
PMID:23677775 |
RGD:8549504 |
NCBI chr 9:7,922,693...7,953,509
Ensembl chr 9:7,922,697...7,953,509
|
|
|
|
|
Pathway Gene Annotations |
References Associated with the acetylcholine signaling pathway:
- Szutowicz A, etal., Neurochem Res. 2013 Aug;38(8):1523-42. doi: 10.1007/s11064-013-1060-x. Epub 2013 May 16.
- McCorry LK Am J Pharm Educ. 2007 Aug 15;71(4):78.
- Prado VF, etal., Biochem J. 2013 Mar 1;450(2):265-74. doi: 10.1042/BJ20121662.
- Drever BD, etal., Behav Brain Res. 2011 Aug 10;221(2):505-14. doi: 10.1016/j.bbr.2010.11.037. Epub 2010 Dec 2.
- Picciotto MR, etal., Neuron. 2012 Oct 4;76(1):116-29. doi: 10.1016/j.neuron.2012.08.036.
- Abreu-Villaca Y, etal., Behav Brain Res. 2011 Aug 10;221(2):367-78. doi: 10.1016/j.bbr.2009.12.049. Epub 2010 Jan 6.
- Kawashima K, etal., Life Sci. 2012 Nov 27;91(21-22):1027-32. doi: 10.1016/j.lfs.2012.05.006. Epub 2012 May 29.
- Nizri E and Brenner T, Amino Acids. 2013 Jul;45(1):73-85. doi: 10.1007/s00726-011-1192-8. Epub 2011 Dec 23.
- Wessler I and Kirkpatrick CJ, Br J Pharmacol. 2008 Aug;154(8):1558-71. doi: 10.1038/bjp.2008.185. Epub 2008 May 26.
|
|
Ontology Path Diagram:
|
Import into Pathway Studio:
|
|